CEL For Pharma

What CEL For Pharma does

CELforPharma B.V. is a privately held Belgium-based professional education business that operates as an international business school for the biopharma and medtech industries. The company delivers a catalog of 33+ specialized short courses spanning four domains — Access-Pricing-HEOR, Medical Affairs, Strategic Pharma Marketing, and Business Development & Licensing — taught by recognized industry practitioners (e.g., Dr Stefan Walzer, Prof. Dr Lieven Annemans, Dr Carlos Velez, Gary & Sam Johnson of Inpharmation). Courses are delivered face-to-face at the Crowne Plaza Brussels Airport and live-online via Zoom, with published fees of €1,570–€3,370 per participant, plus customized In-Company Training Solutions for enterprise teams. The technology layer is lightweight: a web-based course finder and registration platform, Zoom for live delivery, and proprietary teaching artifacts (an Excel forecasting tool, Medical Plan templates, KOL planning templates, and an Advisory Board checklist) that are bundled with course attendance. CELforPharma reports training 1,000+ executives per year from 197 companies across 42 countries in 2025, with an 8.9/10 participant recommendation score, and publicly references logos including Roche, Novartis, Daiichi Sankyo, Boehringer Ingelheim, Chiesi, argenx, Ferring, and Tillotts Pharma. The company is led operationally by Annelies Swaan (COO) and Inge Cornelis (CEO), with founder/CEO Luc De Langhe; it is closely held, employs 1–10 people, has not disclosed external funding, and generates revenue through per-seat course fees and bespoke enterprise training contracts.

Name

CEL For Pharma

Legal name

CELforPharma B.V.

Website

https://celforpharma.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

CELforPharma is a Belgium-based private business school delivering 33+ short courses in market access, medical affairs, strategic pharma marketing, and BD&L to biopharma and medtech professionals globally via Brussels classroom and live-online formats.

Ownership category

akta.pro rank

Product category

Professional Training and Education for Biopharma and Medtech

NAICS

Business Schools and Computer and Management Training (6114)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Pharmaceuticals & Biotechnology (EDABALAU)

akta.pro secondary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Pharma professional training
• Biopharma education
• Market access courses
• Medical affairs training
• Business development licensing

Headquarters

HQ city

Diegem

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Public Course Fees: Fees charged for participation in scheduled public courses (1-day, 2-day formats). Pricing varies by course length and includes early bird discounts. Face-to-face courses held in Brussels; live online courses delivered via Zoom.
2. In-Company Training: Customized training programs delivered in-company (face-to-face or live online) for teams within pharma/biotech organizations. Pricing customized based on focus and needs.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

CELforPharma is an international business school for the Biopharma and Medtech industries that delivers specialized professional training courses across four core domains: Access-Pricing-HEOR, Medical Affairs, Strategic Pharma Marketing, and Business Development & Licensing. It sells per-seat public course registrations (1-day and 2-day formats delivered face-to-face in Brussels or live online via Zoom) and customized in-company training programs for pharma/biotech teams. The company also runs free expert-led webinars as a demand-generation channel.

Product overview

CELforPharma is an international business school for the biopharma and medtech industries, offering a portfolio of professional training courses delivered in both face-to-face (Brussels) and live online formats. The company organizes its course offerings across four primary domains: Access - Pricing - HEOR, Medical Affairs, Strategic Pharma Marketing, and Business Development & Licensing. Courses range from foundational introductions to advanced specializations, covering topics such as AI applications in pharma, market access, health economics, forecasting, BD&L processes, medical affairs strategy, and payer negotiations. The company also offers in-company training solutions for team-based learning and free educational webinars.

Differentiator

Problem solved

Functional benefit

Products and services

• Access - Pricing - HEOR Courses A course domain focused on market access disciplines including pricing and reimbursement systems, payer decision-making, health economics, real-world evidence, and HTA processes for optimal patient access.
• Medical Affairs Courses A course domain covering strategic capabilities for Medical Affairs professionals including omnichannel launches, congress management, real-world evidence generation, KOL engagement, and statistical thinking.
• Strategic Marketing Courses A course domain for pharmaceutical marketing professionals covering brand planning, competitive strategy, loss of exclusivity planning, evidence-based forecasting, digital channels, and AI applications.
• Business Development & Licensing Courses A course domain covering BD&L processes including partnering models, in/out-licensing, company/product valuations, deal structuring, forecasting, and AI applications.
• The AI for Pharma Market Access Course A 2-day hands-on face-to-face course in Brussels on applying AI tools to market access planning, systematic literature reviews, dossier writing, and payer negotiations.
• The Healthcare Payer Negotiations Course A one-day live online course on negotiation skills for engaging with healthcare payers.
• The Medical Plan and Tactical Implementation A business acumen course for MSLs and Medical Advisors on building Medical Plans and tactical implementation.
• Business Development & Licensing Course For Pharma & Biotech An overview course on the BD&L process in pharma-biotech industry covering sourcing, valuation, term sheets, and negotiation fundamentals.
• The Pharma Forecasting Course A course on evidence-based pharmaceutical sales forecasting techniques including epi-based, patient-based, and sales-based forecasts.
• The AI for Pharma Business Development & Licensing Course A course on structured AI approaches in business development and licensing processes.
• The AI for Medical Affairs Course A course on applying AI in Medical Affairs functions.
• Understanding Pharma Market Access & Payers in Europe A course on understanding pharma market access and payer dynamics in European markets.
• Understanding Pharma Market Access in the US A course on understanding US pharma market access dynamics.
• Generating RWE for Optimising Market/Patient Access A course on generating real-world evidence for market and patient access optimization.
• Omnichannel Launch Excellence for Medical & Marketing A course on omnichannel launch strategies for pharmaceutical products.
• In-Company Training Solutions Customized in-house training programs for pharmaceutical teams, available in face-to-face or live online formats with customized pricing based on focus and needs.
• Webinars Free educational webinars featuring expert faculty covering pharmaceutical industry topics, used as a top-of-funnel acquisition channel.

Quantifiable outcome

• 8.9/10 recommendation score from participants
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Crowne Plaza Brussels AirportcoreOthersPreferred venue partner for face-to-face training courses. CELforPharma holds courses at Crowne Plaza Brussels Airport hotel (Da Vincilaan 4, 1831 Brussels) with negotiated preferential room rates for course participants. Hotel provides business hotel environment for focused learning experience.
• CELforPharma Expert FacultycoreOthersInternational expert faculty members including Dr Stefan Walzer (MArS), Dr Carlos Velez (Lacerta Bio), Prof. Dr Lieven Annemans, Maaike Addicks MD, Gary & Sam Johnson (Inpharmation), and others serve as trainers. Faculty are recognized industry leaders with extensive real-world experience in pharma/biotech market access, BD&L, medical affairs, and strategic marketing.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ISPOR (International Society for Pharmacoeconomics and Outcomes Research): Global professional society for health economics and outcomes research (HEOR) and market access, providing conferences, short courses and training. Direct thematic overlap with CELforPharma's Access-Pricing-HEOR domain, but operates through a non-profit membership model at larger scale.
• CBI (now part of Informa Connect): Pharmaceutical and biotech conferences and training provider, now within Informa Connect. Overlaps with CELforPharma on pharma commercial, compliance and market access programming but as part of a wider multi-industry events business.
• Informa (Pharma Intelligence / Pharma events portfolio): Large global events, intelligence and training group with a dedicated pharma portfolio (Pharma Intelligence, Scrip, Pink Sheet, multiple pharma conferences). Competes with CELforPharma on market access, medical affairs and commercial training, but as part of a much broader portfolio and at significantly larger scale.

Direct peers

• DIA (Drug Information Association): Global non-profit association serving pharma, biotech and regulatory professionals with training, conferences and courses across drug development, medical affairs and market access. Directly comparable to CELforPharma in serving pharma professionals with paid education programs, but at materially larger scale and broader topic coverage.
• PharmaTrain Federation: European not-for-profit federation that accredits pharmaceutical medicine and medical affairs training programs across multiple universities and training providers. Comparable as a recognized pharma-specific training organization, but operates via accredited academic partners rather than direct course delivery.
• Reuters Events Pharma: Operates major pharma industry conferences and digital training for commercial, market access and medical affairs executives. Comparable in serving senior pharma/biotech decision-makers with paid educational events and digital content.
• Proventa International: Specialist provider of pharma and biotech training, workshops and summits covering commercial excellence, market access and medical affairs. Closely comparable in vertical specialization, training-led GTM and biopharma customer segment.
• eyeforpharma: Commercial pharma conferences and training focused on market access, commercial excellence, patient engagement and digital strategy. Mirrors CELforPharma's vertical focus on biopharma commercial functions and uses a conference/training/content hybrid GTM model.

Emerging players

• HealthEconomics.Com: Specialist online training and resource hub for health economics, market access and HEOR professionals. Comparable niche focus on HEOR education — one of CELforPharma's four core domains — but more U.S.-anchored and digital/online in distribution.

Others

• IQVIA Institute for Human Data Science: Research and education arm of IQVIA producing reports, executive education and thought leadership for biopharma, including market access and medical affairs topics. Not a direct course competitor but a comparable influence vector on pharma training budgets and content conventions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/school/celforpharma
• Xx.com/CELforpharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CEL For Pharma